Vaccine in National Immunization Programme Update August 2017

Countries using IPV vaccine to date This information is available from the website @: IPV Introduction, OPV Withdrawal and Routine Immunization Strengthening: http://www.who.int/immunization/diseases/poliomyelitis/in activated_polio_vaccine/en/ (click on the hyperlink to access the website – on its right hand column a slide set presentation in downloadable)

Countries with Hib vaccine in the national immunization programme; and planned introductions in 2017 Introduced* to date Afghanistan, Albania, Algeria, Andorra, Angola, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Canada, Central African Republic, Chad, Chile, Colombia, Comoros, Congo, Cook Islands, Costa Rica, Côte d'Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Democratic People's Republic of Korea, Democratic Republic of the Congo, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Fiji, Finland, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia (Federated States of ), Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Korea, Republic of Moldova, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Tajikistan, The former Yugoslav Republic of Macedonia, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela, Viet Nam, Yemen, Zambia, Zimbabwe Planned introductions in Belarus Not Available, Not Introduced/No Plans China, Russian Federation, Thailand Introduced* to date (191 countries or 98%) Not Available, Not Introduced/No Plans * Includes partial introduction (3 countries or 2%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2017. All rights reserved. Data source: WHO/IVB Database, as of 09 August 2017 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

Countries with Pneumococcal Conjugate vaccine in the national immunization programme; and planned introductions in 2017 Introduced* to date Afghanistan, Albania, Algeria, Andorra, Angola, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belgium, Benin, Bolivia, Botswana, Brazil, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Central African Republic, Chile, Colombia, Congo, Costa Rica, Côte d'Ivoire, Cyprus, Democratic Republic of the Congo, Denmark, Djibouti, Dominican Republic, Ecuador, El Salvador, Eritrea, Ethiopia, Fiji, Finland, France, Gambia, Georgia, Germany, Ghana, Greece, Guatemala, Guinea-Bissau, Guyana, Honduras, Hungary, Iceland, Iraq, Ireland, Israel, Italy, Japan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Mali, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia (Federated States of ), Monaco, Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Portugal, Qatar, Republic of Korea, Republic of Moldova, Russian Federation, Rwanda, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, South Africa, Sudan, Swaziland, Sweden, Switzerland, Togo, Trinidad and Tobago, Turkey, Uganda, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Venezuela, Yemen, Zambia, Zimbabwe Partial Introduction in Mongolia, Nigeria and the Philippines Planned introductions in 2017 India, Indonesia, Seychelles, Suriname Not Available, Not Introduced/No Plans Antigua and Barbuda, Belarus, Belize, Bhutan, Bosnia and Herzegovina, Brunei Darussalam, Cabo Verde, Chad, China, Comoros, Cook Islands, Croatia, Cuba, Czech Republic, Democratic People's Republic of Korea, Dominica, Egypt, Equatorial Guinea, Estonia, Gabon, Grenada, Guinea, Haiti, Iran (Islamic Republic of), Jamaica, Jordan, Malaysia, Maldives, Malta, Montenegro, Nauru, Poland, Romania, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Serbia, Somalia, South Sudan, Spain, Sri Lanka, Syrian Arab Republic, Tajikistan, Thailand, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Tunisia, Turkmenistan, Tuvalu, Ukraine, Vanuatu, Viet Nam Introduced* to date (136 countries or 70%) Planned introductions in 2017 (4 countries or 2%) Not Available, Not Introduced/No Plans * Includes partial introduction (54 countries or 28%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2017. All rights reserved. Data source: WHO/IVB Database, as of 09 August 2017 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

Countries with Rotavirus vaccine in the national immunization programme; and planned introductions in 2017 Introduced* to date Angola, Argentina, Armenia, Australia, Austria, Bahrain, Belgium, Bolivia, Botswana, Brazil, Burkina Faso, Burundi, Cameroon, Canada, Colombia, Congo, Côte d'Ivoire, Djibouti, Dominican Republic, Ecuador, El Salvador, Eritrea, Estonia, Ethiopia, Fiji, Finland, Gambia, Georgia, Germany, Ghana, Greece, Guatemala, Guinea-Bissau, Guyana, Haiti, Honduras, India, Iraq, Ireland, Israel, Italy, Jordan, Kenya, Kiribati, Latvia, Liberia, Libya, Luxembourg, Madagascar, Malawi, Mali, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia (Federated States of ), Morocco, Mozambique, Namibia, New Zealand, Nicaragua, Niger, Norway, Pakistan, Palau, Panama, Paraguay, Peru, Qatar, Republic of Moldova, Russian Federation, Rwanda, Sao Tome and Principe, Saudi Arabia, Senegal, Sierra Leone, South Africa, Sudan, Swaziland, Sweden, Tajikistan, Togo, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uzbekistan, Venezuela, Yemen, Zambia, Zimbabwe Partial introduction in Canada, India, Italy, Pakistan Planned introductions in 2017 Belize, Central African Republic, Lesotho, Nigeria, Seychelles, Uganda Not Available, Not Introduced/No Plans Afghanistan, Albania, Algeria, Andorra, Antigua and Barbuda, Azerbaijan, Bahamas, Bangladesh, Barbados, Belarus, Benin, Bhutan, Bosnia and Herzegovina, Brunei Darussalam, Bulgaria, Cabo Verde, Cambodia, Chad, Chile, China, Comoros, Cook Islands, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Democratic People's Republic of Korea, Democratic Republic of the Congo, Denmark, Dominica, Egypt, Equatorial Guinea, France, Gabon, Grenada, Guinea, Hungary, Iceland, Indonesia, Iran (Islamic Republic of), Jamaica, Japan, Kazakhstan, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Lebanon, Lithuania, Malaysia, Maldives, Malta, Monaco, Mongolia, Montenegro, Myanmar, Nauru, Nepal, Netherlands, Niue, Oman, Papua New Guinea, Philippines, Poland, Portugal, Republic of Korea, Romania, Russian Federation, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Serbia, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Sudan, Spain, Sri Lanka, Suriname, Switzerland, Syrian Arab Republic, Thailand, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Ukraine, Uruguay, Vanuatu, Viet Nam Introduced* to date (91 countries or 47%) Planned introductions in 2017 (6 countries or 3%) Not Available, Not Introduced/No Plans * Includes partial introduction (97 countries or 50%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2017. All rights reserved. Data source: WHO/IVB Database, as of 09 August 2017 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

Countries with HPV vaccine in the national immunization programme Introduced* to date Andorra, Argentina, Australia, Austria, Bahamas, Barbados, Belgium, Belize, Bhutan, Bolivia, Botswana, Brazil, Brunei Darussalam, Canada, Chile, Colombia, Cook Islands, Croatia, Cyprus, Czech Republic, Denmark, Ecuador, Fiji, Finland, France, Germany, Greece, Honduras, Hungary, Iceland, Ireland, Israel, Italy, Japan, Latvia, Lesotho, Libya, Lithuania, Luxembourg, Malaysia, Malta, Marshall Islands, Mexico, Micronesia (Federated States of ), Monaco, Netherlands, New Zealand, Norway, Palau, Panama, Paraguay, Peru, Philippines, Portugal, Republic of Korea, Russian Federation, Rwanda, San Marino, Seychelles, Singapore, Slovenia, South Africa, Spain, Sri Lanka, Suriname, Sweden, Switzerland, The former Yugoslav Republic of Macedonia, Trinidad and Tobago, Turkmenistan, Uganda, United Kingdom, United States of America, Uruguay Partial introduction in the Philippines and Russian Federation Not Available, Not Introduced/No Plans Afghanistan, Albania, Algeria, Angola, Antigua and Barbuda, Armenia, Azerbaijan, Bahrain, Bangladesh, Belarus, Benin, Bosnia and Herzegovina, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Central African Republic, Chad, China, Comoros, Congo, Costa Rica, Côte d'Ivoire, Cuba, Democratic People's Republic of Korea, Democratic Republic of the Congo, Djibouti, Dominica, Dominican Republic, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Gabon, Gambia, Georgia, Ghana, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, India, Indonesia, Iran (Islamic Republic of), Iraq, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Lebanon, Liberia, Madagascar, Malawi, Maldives, Mali, Mauritania, Mauritius, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Papua New Guinea, Poland, Qatar, Republic of Moldova, Romania, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Sierra Leone, Slovakia, Solomon Islands, Somalia, South Sudan, Sudan, Swaziland, Syrian Arab Republic, Tajikistan, Thailand, Timor-Leste, Togo, Tonga, Tunisia, Turkey, Tuvalu, Ukraine, United Arab Emirates, United Republic of Tanzania, Uzbekistan, Vanuatu, Venezuela, Viet Nam, Yemen, Zambia, Zimbabwe Introduced* to date (74 countries or 38.1%) Not Available, Not Introduced/No Plans (120 countries or 61.9%) * Includes partial introduction Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2017. All rights reserved. Data source: WHO/IVB Database, as of 09 August 2017 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

Countries using Measles Second Dose vaccine to date; and planned introductions in 2017 Introduced to date Afghanistan, Albania, Algeria, Andorra, Angola, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Bhutan, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Canada, Chile, China, Colombia, Cook Islands, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Democratic People's Republic of Korea, Denmark, Djibouti, Dominica, Ecuador, Egypt, El Salvador, Eritrea, Estonia, Fiji, Finland, France, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guyana, Haiti, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Latvia, Lebanon, Lesotho, Libya, Lithuania, Luxembourg, Malawi, Malaysia, Maldives, Malta, Marshall Islands, Mauritius, Mexico, Micronesia (Federated States of ), Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Korea, Republic of Moldova, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Tajikistan, Thailand, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Ukraine, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Venezuela, Viet Nam, Yemen, Zambia, Zimbabwe Planned introductions in 2017 Cameroon, Comoros, Congo, Lao People's Democratic Republic, Namibia, Solomon Islands, Uganda Not Available, Not Introduced/No Plans Benin, Bolivia, Central African Republic, Chad, Côte d'Ivoire, Democratic Republic of the Congo, Dominican Republic, Equatorial Guinea, Ethiopia, Gabon, Guinea, Guinea-Bissau, Honduras, Liberia, Madagascar, Mali, Mauritania, Nigeria, Somalia, South Sudan, Togo, Vanuatu Introduced to date (165 countries or 85.1%) Planned introductions in 2017 (7 countries or 3.6%) Not Available, Not Introduced/No Plans (22 countries or 11.3%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2017. All rights reserved. Data source: WHO/IVB Database, as of 09 August 2017 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

Countries with Rubella vaccine in the national immunization programme; and planned introductions in 2017 Introduced to date Albania, Algeria, Andorra, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Canada, Chile, China, Colombia, Cook Islands, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Fiji, Finland, France, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guyana, Haiti, Honduras, Hungary, Iceland, India, Iran (Islamic Republic of), Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Libya, Lithuania, Luxembourg, Malaysia, Maldives, Malta, Marshall Islands, Mauritius, Mexico, Micronesia (Federated States of ), Monaco, Mongolia, Montenegro, Morocco, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niue, Norway, Oman, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Korea, Republic of Moldova, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Singapore, Slovakia, Slovenia, Solomon Islands, Spain, Sri Lanka, Suriname, Swaziland, Sweden, Switzerland, Syrian Arab Republic, Tajikistan, Thailand, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Ukraine, United Arab Emirates, United Kingdom, United Republic of Tanzania, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela, Viet Nam, Yemen, Zambia, Zimbabwe Patial introduction in India and Lesotho Planned introductions in 2017 Angola, Gambia, Malawi, Mozambique, Sierra Leone Not Available, Not Introduced/No Plans Afghanistan, Benin, Central African Republic, Chad, Comoros, Congo, Côte d'Ivoire, Democratic People's Republic of Korea, Democratic Republic of the Congo, Djibouti, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Guinea, Guinea-Bissau, Indonesia, Liberia, Madagascar, Mali, Mauritania, Niger, Nigeria, Pakistan, Somalia, South Africa, South Sudan, Sudan, Togo, Uganda Introduced to date* (159 countries or 82%) Planned introductions in 2017 (5 countries or 2.6%) Not Available, Not Introduced/No Plans * Includes partial introduction (30 countries or 15.5%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2017. All rights reserved. Data source: WHO/IVB Database, as of 09 August 2017 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

Countries with Mumps containing vaccine in the national immunization programme Introduced* to date (121 countries or 62%) Not Available, Not Introduced/No Plans (73 countries or 38%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2017. All rights reserved. Data source: WHO/IVB Database, as of 09 August 2017 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

Countries with Hepatitis B Birth dose (HepB-BD) vaccine in the national immunization programme HepB-BD introduced to date: Afghanistan Albania Algeria Andorra Argentina Armenia Australia Azerbaijan Bahrain Belarus Bhutan Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Cambodia Cabo Verde China Colombia Cook Islands Costa Rica Cuba Democratic People’s Republic of Korea (the) Djibouti Dominican Republic (the) Ecuador Egypt El Salvador Estonia Fiji Gambia (the) Georgia Guatemala Honduras India Indonesia Iran (Islamic Republic of) Iraq Israel Kazakhstan Kiribati Kuwait Kyrgyzstan Lao People’s Democratic Republic (the) Lebanon Libya Lithuania Malaysia Maldives Marshall Islands (the) Mauritania Mexico Micronesia (Federated States of) Mongolia Morocco Myanmar Namibia Nauru Nigeria Niue Oman Palau Panama Papua New Guinea Peru Philippines (the) Poland Portugal Qatar Republic of Korea (the) Republic of Moldova (the) Romania Russian Federation (the) Saint Kitts and Nevis Saint Lucia Samoa Saudi Arabia Senegal Serbia Singapore Solomon Islands Spain Suriname Syrian Arab Republic (the) Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Tunisia Turkey Turkmenistan Tuvalu Ukraine United Arab Emirates (the) United States of America (the) Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Viet Nam HepB-BD only for infants born to HBsAG-positive mothers Belgium Czech Republic (the) Denmark Dominica France Greece Italy Latvia Luxembourg Monaco Netherlands (the) New Zealand Norway Paraguay Sao Tome and Principe Slovakia Slovenia Sweden Switzerland United Kingdom of Great Britain and Northern Ireland (the) HepB in schedule but no HepB-BD Angola Antigua and Barbuda Austria Bahamas (the) Bangladesh Barbados Belize Benin Bolivia (Plurinational State of) Burkina Faso Burundi Cameroon Canada Central African Republic (the) Chad Chile Comoros (the) Congo (the) Côte d'Ivoire Croatia Cyprus Democratic Republic of the Congo (the) Equatorial Guinea Eritrea Ethiopia Gabon Germany Ghana Grenada Guinea Guinea-Bissau Guyana Haiti Ireland Jamaica Japan Jordan Kenya Lesotho Liberia Madagascar Malawi Mali Malta Mauritius Montenegro Mozambique Nepal Nicaragua Niger (the) Pakistan Rwanda Saint Vincent and the Grenadines San Marino Seychelles Sierra Leone Somalia South Africa South Sudan Sri Lanka Sudan (the) Swaziland Togo Trinidad and Tobago Uganda United Republic of Tanzania (the) Uruguay Yemen Zambia Zimbabwe HepB given only for risk groups or adolescents Finland Hungary Iceland HepB-BD introduced to date (100 countries or 52%) HepB-BD only for infants born to HBsAG-positive mothers (21 countries or 11%) (70 countries or 36%) HepB in schedule but no HepB-BD Data source: WHO/IVB Database as at 9 August 2017 and ECDC published data at http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx 194 WHO Member States Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 9 August 2017 HepB given only for risk groups or adolescents (3 countries or 2%) Not available The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2017. All rights reserved. Not applicable

Countries and Territories using Yellow fever* vaccine to date Introduced to date Angola, Benin, Bolivia (Plurinational State of), Burkina Faso, Cameroon, Central African Republic (the), Chad, Colombia, Congo (the), Côte d'Ivoire, Democratic Republic of the Congo (the), Ecuador, French Guyana, Gabon, Gambia (the), Ghana, Guinea, Guinea-Bissau, Guyana, Kenya, Liberia, Mali, Niger (the), Nigeria, Paraguay, Peru, Senegal, Sierra Leone, Suriname, Togo, Trinidad and Tobago, Venezuela (Bolivarian Republic of) Sao Tome Y Principe and Seychelles introduced but are not listed as at risk countries. Introduced in High risk areas Argentina, Brazil, Panama At risk but not introduced Burundi, Equatorial Guinea, Ethiopia, Mauritania, Rwanda, Somalia, South Sudan, Sudan (the), Uganda Introduced to date (32 countries or 73%) Introduced in Hig risk areas (3 countries or 7%) At risk but not introduced (9 countries or 20%) * WHO considers that 44 countries/Territories are at risk for Yellow fever Not Available / Not at risk Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2017. All rights reserved. Data source: WHO/IVB Database, as of 09 August 2017 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization

Countries and Territories using JE vaccine to date At risk countries/areas but not introduced Bangladesh, Bhutan, Brunei Darussalam, Democratic People’s Republic of Korea (the), Indonesia, Myanmar, Pakistan, Philippines (the), Russian Federation and Singapore Introduced to date China, Japan, Republic of Korea, Sri Lanka, Thailand Introduced in the high risk areas: Australia Introduced in parts of the country Cambodia, India, Lao People's Democratic Republic, Malaysia, Nepal, Viet Nam At risk countries/areas but not introduced (11 countries or 50%) Introduced to date (6 countries or 27%) Introduced in parts of the country (5 countries or 23%) Not applicable Data source: WHO/IVB Database, as of 09 August 2017 International travel Health Database (http://www.who.int/wer/2013/wer8834.pdf?ua=1) Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2017. All rights reserved.